MEK

Biotech investing using information arbitrage.

[MEK @Dragon_Point]

Trying to find Recombinant Human Ciliary Neurotropic Factor - 20ug ASAP - critical mission need ASAP. Please reach out if you can help.

[MEK @Dragon_Point]

@SunWeatherMan Where TF were you yesterday??? Biggest event and ??? I had to find alternative info — bye

[MEK @Dragon_Point]

@splendid_pete @Biomaven Yeah and all this focus on drug prices IS NOT going to solve the problem.

[MEK @Dragon_Point]

@JoeSquawk
Regarding US Stem: There is a deeper story here being missed. My son is a Junior (chem e) at a private Florida tech college, and all of his STEM friends are having a hard time getting jobs. He has a 3.9 with a solid resume and applied to 60 internships “opportunities” and had no follow ups. Same with many of his friends.

[HODOR @Maximus_Holla]

$IXHL wen sleep Apnea treasury PR ?

[MEK @Dragon_Point]

@elonmusk Exactly.

[MEK @Dragon_Point]

@MartinShkreli Enron repeat

[HODOR @Maximus_Holla]

@jfais20 You have the conviction!

[MEK @Dragon_Point]

@appalachiangabe @Lotterystonks Do you have a link to ruling? Doesn’t seem to be readily available yet on FERC site. TIA

[MEK @Dragon_Point]

$vktx Let me help you guys who haven’t learned how to use the internet yet:

… found on company website… 🤪

For special needs - this is Central Time.

[MEK @Dragon_Point]

@MattNachtrab @CNBC @JoeSquawk @BeckyQuick Same here

[SpaceWeatherNews @SunWeatherMan]

Unvaccinated sperm is the new Bitcoin

[stockbee @PradeepBonde]

Wait for volatility to get lower or use wider stop

[MEK @Dragon_Point]

I hope it works better for you and your patients than it has for me. I found it very unreliable in terms of actual weight measurements (extremely variable - compared to traditional scale - lbs of variability in one day) and very frustrating to use and terrible tech support. Low expectations as for any fat % measurement. But weight should not have been a challenge. Good luck.

[MEK @Dragon_Point]

@eventdiver Agreed.

[MEK @Dragon_Point]

$CTLT From Q4 2023 Earnings Call Q&A:
Sean Dodge, RBC Capital Markets:
So maybe going back to the guidance one more time. The significant growth you are expecting from the gene therapy customer, how dependent is that on the EMBARK data that will come out later this year? How big of a swing factor does that have the potential to be for you all if that readout, good versus bad and how are you handicapping that for the purposes of the guidance?
Matti MasanovichAny upside, none of that is included. So if it does get expanded -- label doesn’t expanded. It’s not included in the forecast.

[MEK @Dragon_Point]

Yes I think other analysts have erroneously identified the customer as $SRPT based on the numbers attributed - those numbers are for this other customer. NOT $SRPT:
1. Statement on the CC by $CTLT management as NOT being $SRPT.
2. The programs attributed to the GT customer do not match $SRPT.
3. The numbers stated coming from this other GT customer can not be reconciled by several SEC filings that I have reviewed for both $CTLT and $SRPT.